SLC22A5 was significantly decreased in motor neurons of the spinal cord of human ALS patients (n = 7) compared to normal subjects (n = 7), indicating the altered expression of carnitine transporters in human ALS patients (Figure A1b). This evidence concerns the gene SLC22A5 and amyotrophic lateral sclerosis.